Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Samson

Showing results (101-110 of 181) with videos related to

Pageof 19
Sort By:
Rheumatology (Oxford, England)|July 22, 2022
PET/CT of cranial arteries for a sensitive diagnosis of giant cell arteritisThomas Thibault, Bastien Durand-Bailloud, Agnès Soudry-Faure, et al.
Frontiers in Immunology|March 29, 2022
Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHDClaire Gérard, Marine Thébault, Baptiste Lamarthée, et al.
European Journal of Internal Medicine|February 21, 2021
Myocardial infarction during giant cell arteritis: A cohort studyHélène Greigert, Marianne Zeller, Alain Putot, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2015
Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytesNona Janikashvili, Malika Trad, Alexandrine Gautheron, et al.
Presse Medicale (Paris, France : 1983)|July 10, 2020
ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenanceBenjamin Terrier, Pierre Charles, Olivier Aumaître, et al.
Rheumatology (Oxford, England)|December 14, 2025
Diffuse alveolar hemorrhage in antiphospholipid syndrome: a French series of 26 patientsVincent Grobost, Mélanie Ramos, Cécile Yelnik, et al.
European Journal of Haematology|May 4, 2026
Efficacy and Tolerance of Cladribine for Non-Langerhans Cell HistiocytosisQuentin Riller, Thouraya Ben Salem, Jean-François Emile, et al.
European Journal of Internal Medicine|July 29, 2018
Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective studyMaxime Samson, Hervé Devilliers, Kim Heang Ly, et al.
RMD Open|March 27, 2026
Complete PET/CT extinction and subsequent risk of aortic dilation in patients with giant cell arteritis-related large vessel vasculitis treated with tocilizumabAnaël Dumont, Olivier Espitia, Maxime Samson, et al.
Blood|August 31, 2011
Immunologic effects of rituximab on the human spleen in immune thrombocytopeniaSylvain Audia, Maxime Samson, Julien Guy, et al.
Pageof 19

Showing results (101-110 of 181) with videos related to

Sort By:
Pageof 19
Rheumatology (Oxford, England)|July 22, 2022
PET/CT of cranial arteries for a sensitive diagnosis of giant cell arteritisThomas Thibault, Bastien Durand-Bailloud, Agnès Soudry-Faure, et al.
Frontiers in Immunology|March 29, 2022
Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHDClaire Gérard, Marine Thébault, Baptiste Lamarthée, et al.
European Journal of Internal Medicine|February 21, 2021
Myocardial infarction during giant cell arteritis: A cohort studyHélène Greigert, Marianne Zeller, Alain Putot, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2015
Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytesNona Janikashvili, Malika Trad, Alexandrine Gautheron, et al.
Presse Medicale (Paris, France : 1983)|July 10, 2020
ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenanceBenjamin Terrier, Pierre Charles, Olivier Aumaître, et al.
Rheumatology (Oxford, England)|December 14, 2025
Diffuse alveolar hemorrhage in antiphospholipid syndrome: a French series of 26 patientsVincent Grobost, Mélanie Ramos, Cécile Yelnik, et al.
European Journal of Haematology|May 4, 2026
Efficacy and Tolerance of Cladribine for Non-Langerhans Cell HistiocytosisQuentin Riller, Thouraya Ben Salem, Jean-François Emile, et al.
European Journal of Internal Medicine|July 29, 2018
Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective studyMaxime Samson, Hervé Devilliers, Kim Heang Ly, et al.
RMD Open|March 27, 2026
Complete PET/CT extinction and subsequent risk of aortic dilation in patients with giant cell arteritis-related large vessel vasculitis treated with tocilizumabAnaël Dumont, Olivier Espitia, Maxime Samson, et al.
Blood|August 31, 2011
Immunologic effects of rituximab on the human spleen in immune thrombocytopeniaSylvain Audia, Maxime Samson, Julien Guy, et al.
Pageof 19